Trump’s FDA Cuts Are Putting Drug Development at Risk
New SEC filings from pharmaceutical companies reveal Donald Trump and Elon Musk’s cost-cutting measures could slow drug ...
Through ‘radical transparency,’ Kennedy can finally rein in Big Pharma
Kennedy can provide doctors and healthcare professionals with the information they need to truly determine if a drug is safe, ...
Trump's FDA Staff Cuts Weigh on Agency's Drug Oversight Work
The Trump administration’s moves to shrink the federal workforce put the FDA’s ability to regulate drugs and oversee the ...
FDA employees now lack the tools to do their jobs
Many critical functions of the food division of the Food and Drug Administration have been drastically slowed or entirely stopped since late ...
Business Insider13d
VANTAGE FILES FDA DRUG MASTER FILE FOR VYCERIN™ API GLYCERIN, USP DESIGNED SPECIFICALLY TO MEET PHARMACEUTICAL FORMULATION NEEDS
with the U.S. Food and Drug Administration (FDA). This first-to-market active pharmaceutical ingredient (API) grade glycerin is manufactured and packaged in the United States to ICH Q7 standards ...
NJBIZ8d
FDA alerts NJ pharma over ‘misleading’ cancer drug claims at conference
The U.S. Food and Drug Administration scolded a Parsippany-based pharmaceutical company for allegedly making misleading claims about its multiple myeloma drug at a conference exhibit booth.
Nasdaq7d
ARS Pharma : FDA Approves Neffy 1 Mg For Type I Allergic Reactions In Pediatric Patients
(RTTNews) - ARS Pharmaceuticals Inc. (SPRY) announced that the U.S. Food and Drug Administration has approved neffy 1 mg (epinephrine nasal spray) for the treatment of Type I Allergic Reactions ...
Fierce Pharma9d
Pfizer could shift overseas production to US if Trump's pharma tariffs take hold, CEO says
As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...